Morgan Stanley initiated coverage on GW Pharma (NASDAQ: GWPH) with an
Overweight rating and a price target of $103.00. Analyst David Friedman
thinks the company's novel cannabis platform and epilepsy drug will drive
value.
E**********r 发帖数: 2743
2
thanks for sharing the info! i used to pay attention to GW Pharma when it
was in the spot light. it's good to know there's a reason to do so once
again.
T**M 发帖数: 658
3
又开始拉了
T**M 发帖数: 658
4
继续拉升
E**********r 发帖数: 2743
5
GWPH涨得不错，so far ＋14.60%。
貌似这种暴力拉升扮靓上涨的momentum不错，可以第二天跟进DT一把。
WB，GWPH，SRPT最近都是这种走法。
